Hepion Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 1.36
| HEPA Stock | USD 0.49 0.04 7.55% |
Hepion |
Hepion Pharmaceuticals Target Price Odds to finish below 1.36
The tendency of Hepion Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 1.36 after 90 days |
| 0.49 | 90 days | 1.36 | close to 99 |
Based on a normal probability distribution, the odds of Hepion Pharmaceuticals to stay under $ 1.36 after 90 days from now is close to 99 (This Hepion Pharmaceuticals probability density function shows the probability of Hepion Stock to fall within a particular range of prices over 90 days) . Probability of Hepion Pharmaceuticals price to stay between its current price of $ 0.49 and $ 1.36 at the end of the 90-day period is close to 99 .
Given the investment horizon of 90 days Hepion Pharmaceuticals has a beta of 0.29. This usually indicates as returns on the market go up, Hepion Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Hepion Pharmaceuticals will be expected to be much smaller as well. Additionally Hepion Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Hepion Pharmaceuticals Price Density |
| Price |
Predictive Modules for Hepion Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hepion Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Hepion Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Hepion Pharmaceuticals is not an exception. The market had few large corrections towards the Hepion Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hepion Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hepion Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.37 | |
β | Beta against Dow Jones | 0.29 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | -0.07 |
Hepion Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hepion Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hepion Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Hepion Pharmaceuticals generated a negative expected return over the last 90 days | |
| Hepion Pharmaceuticals has high historical volatility and very poor performance | |
| Hepion Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Hepion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (48.93 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hepion Pharmaceuticals currently holds about 59.15 M in cash with (40.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Hepion Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd. |
Hepion Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hepion Stock often depends not only on the future outlook of the current and potential Hepion Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hepion Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4 M | |
| Cash And Short Term Investments | 14.8 M |
Hepion Pharmaceuticals Technical Analysis
Hepion Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Hepion Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hepion Pharmaceuticals. In general, you should focus on analyzing Hepion Stock price patterns and their correlations with different microeconomic environments and drivers.
Hepion Pharmaceuticals Predictive Forecast Models
Hepion Pharmaceuticals' time-series forecasting models is one of many Hepion Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Hepion Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Hepion Pharmaceuticals
Checking the ongoing alerts about Hepion Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hepion Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Hepion Pharmaceuticals generated a negative expected return over the last 90 days | |
| Hepion Pharmaceuticals has high historical volatility and very poor performance | |
| Hepion Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Hepion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (48.93 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hepion Pharmaceuticals currently holds about 59.15 M in cash with (40.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Hepion Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd. |
Check out Hepion Pharmaceuticals Backtesting, Hepion Pharmaceuticals Valuation, Hepion Pharmaceuticals Correlation, Hepion Pharmaceuticals Hype Analysis, Hepion Pharmaceuticals Volatility, Hepion Pharmaceuticals History as well as Hepion Pharmaceuticals Performance. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.40) | Return On Assets (0.93) | Return On Equity (1.90) |
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.